BrUOG 329 Onivyde & Metronomic Temozolomide in Recurrent Glioblastoma
Clinical trial NCT03119064 · TERMINATED
Trial details
- NCT number
- NCT03119064
- Sponsor
- Brown University
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-30
- Primary completion
- 2020-04-10
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.